Economist Mark Zandi has predicted the US economy is on the brink of a recession. Now he shares the reasons why and how bad ...

Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more ...

But layoffs, unfilled vacancies and other proactive measures are taking away from companies’ focus on their long-term futures ...

For the first time since 2020, CEOs planning to shrink their workforce exceeded the share looking to expand,” the Conference ...

"Among the fastest drops ever recorded in a Gartner survey, 78% of CEOs indicated they're implementing cost-cutting measures to safeguard performance," Hall said, according to an AlphaSense transcript ...

Though HCA lifted its 2025 outlook, softer volume and Medicaid growth brought more questions from investors.

Hungary’s economy eked out economic growth in the second quarter, averting a recession but underscoring Prime Minister Viktor Orban’s challenge before next year’s elections.

Games Microsoft confirms it made $27 billion after laying off 9,000 people, and its CEO physically cannot stop talking about AI: "Cloud and AI is the driving force of business transformation ...

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs.

The company named insider Shailesh Jejurikar as CEO to steer it through tariff uncertainty.

Novo Nordisk (NVO) stock falls as the company names a new CEO and cuts outlook citing pressure on obesity drug sales. Eli Lilly (LLY) also drop. Read more here.

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and named a new CEO.